Wednesday 31 October 2012

Statin treatment is associated with a higher death rate and a higher risk of heart attack in angioplasty patients

0 comments
This study was published in the New England Journal of Medicine 1994 Nov 17;331(20):1331-7
 
Study title and authors:
Lack of effect of lovastatin on restenosis after coronary angioplasty. Lovastatin Restenosis Trial Study Group.
Weintraub WS, Boccuzzi SJ, Klein JL, Kosinski AS, King SB 3rd, Ivanhoe R, Cedarholm JC, Stillabower ME, Talley JD, DeMaio SJ
Department of Medicine, Emory University School of Medicine, Atlanta, GA.
 
This study can be accessed at: http://www.ncbi.nlm.nih.gov/pubmed/7935702

This six month, randomized, double-blind trial evaluated the effects of lovastatin in 404 patients who had undergone angioplasty. (Angioplasty is the technique of mechanically widening narrowed or obstructed arteries). The patients received either lovastatin (40 mg orally twice daily) or placebo.

The study found:
(a) Patients receiving lovastatin had a 200% increased risk of death compared to the patients receiving placebo.
(b) Patients receiving lovastatin had a 177% increased risk of a heart attack compared to the patients receiving placebo.

The data from the study reveals that statin treatment is associated with a higher death rate and a higher risk of heart attack in angioplasty patients.
Read more ►

Monday 29 October 2012

Increasing dietary saturated fat is associated with a reduction in breast cancer risk

0 comments
This study was published in the American Journal of Epidemiology 1992 Dec 1;136(11):1327-37
 
Study title and authors:
Diet in the epidemiology of postmenopausal breast cancer in the New York State Cohort.
Graham S, Zielezny M, Marshall J, Priore R, Freudenheim J, Brasure J, Haughey B, Nasca P, Zdeb M.
Department of Social and Preventive Medicine, State University of New York 14214.
 
This study can be accessed at: http://www.ncbi.nlm.nih.gov/pubmed/1336931

The study investigated the association of dietary fat consumption with the risk of breast cancer. The dietary histories of 18,586 postmenopausal women were analysed over a seven year period.

Regarding saturated fat consumption, the study found that for every 10 gram per day increase in saturated fat there was a 10% reduction in the risk of breast cancer.
Read more ►

Sunday 28 October 2012

Statins double the risk of death in patients with coronary artery disease

0 comments
This study was published in the Annals of Internal Medicine 1993 Nov 15;119(10):969-76

Study title and authors:
Coronary angiographic changes with lovastatin therapy. The Monitored Atherosclerosis Regression Study (MARS).
Blankenhorn DH, Azen SP, Kramsch DM, Mack WJ, Cashin-Hemphill L, Hodis HN, DeBoer LW, Mahrer PR, Masteller MJ, Vailas LI, Alaupovic P, Hirsch LJ; MARS Research Group.
University of Southern California, Los Angeles.

This study can be accessed at: http://www.ncbi.nlm.nih.gov/pubmed/8214993

This randomized, double-blind, placebo-controlled, multicenter study assessed the effects of lovastatin in patients with coronary artery disease. The trial included 270 patients, 37 to 67 years old who received either 80 mg/day of lovastatin, or placebo.

The study found that the patients receiving lovastatin had a 104% increased risk of death.
Read more ►

Statins are associated with higher death rates, higher cardiac death rates and increased risk of cancer

0 comments
This study was published in Circulation 2000 Oct 10;102(15):1748-54
 
Study title and authors:
Long-term effects of cholesterol lowering and angiotensin-converting enzyme inhibition on coronary atherosclerosis: The Simvastatin/Enalapril Coronary Atherosclerosis Trial (SCAT).
Teo KK, Burton JR, Buller CE, Plante S, Catellier D, Tymchak W, Dzavik V, Taylor D, Yokoyama S, Montague TJ.
University of Alberta Hospitals, Edmonton, Alberta, Canada. teok@fhs.mcmaster.ca
 
This study can be accessed at: http://www.ncbi.nlm.nih.gov/pubmed/11023927

One of the aims of this long-term, multicenter, randomized, double-blind, placebo-controlled trial was to evaluate the effects of simvastatin in patients with normal cholesterol levels and with detectable plaque build up in at least three major coronary artery segments. The study lasted for four years and included  a total of 460 patients: 230 received simvastatin and 230, a placebo.

The study found:
(a) The patients receiving simvastatin had a 117% increased risk of death compared to the patients receiving placebo.
(b) The patients receiving simvastatin had a 76% increased risk of cardiac death compared to the patients receiving placebo.
(c) The patients receiving simvastatin had a 225% increased risk of non-cardiac death compared to the patients receiving placebo.
(d) The patients receiving simvastatin had a 9% increased risk of a heart attack compared to the patients receiving placebo.
(e) The patients receiving simvastatin had a 78% increased risk of cancer compared to the patients receiving placebo.

The data from the study reveals that statins are associated with higher death rates, higher cardiac death rates and increased risk of cancer. 
Read more ►

Saturday 27 October 2012

How soy phytosterols are manufactured. Would you really want to feed your family this processed poison?

0 comments
This paper was published in Bioresource Technology 2010 Mar;101(5):1471-6
 
Study title and authors;
Recovery of phytosterols from waste residue of soybean oil deodorizer distillate.
Yang H, Yan F, Wu D, Huo M, Li J, Cao Y, Jiang Y.
Key Laboratory of Hollow Fiber Membrane Materials and Processes of the Ministry of Education, School of Material Science and Chemical Engineering, Tianjin Polytechnic University, Tianjin 300160, PR China.
 
This paper can be accessed at: http://www.ncbi.nlm.nih.gov/pubmed/19800221
 
This study describes a crystallization process used to recover soy phytosterols from the waste residue of soybean oil deodorizer distillate (WRSODD).
 
Where does the waste residue of soybean oil deodorizer distillate originate from?
 
Intially oil is extracted from soybeans using a solvent called hexane. (Hexane is a chemical byproduct of gasoline refining and has been identified by the FDA as a potent neurotoxin and a carcinogen.).  The oil is then refined, sometimes hydrogenated and is sold as vegetable oil, or ends up in a wide variety of processed foods. The refining process includes (i) degumming, (ii) neutralization, (iii) bleaching and (iv) deodorization.
 
(i) Degumming:
Crude soy oil contains gums such as phospholipids and other compounds that require removal before the deodorization stage, as they cause the oil to darken when heated. Extracted phospholipids are sold as lecithin. Solvents such as phosphoric acid and acetic anhydride are used in the degumming process. (Phosphoric acid is a corrosive acid and can form toxic fumes whact with other compounds. Acetic anhydride causes skin and eye burns and irritation of the respiratory tract. Nausea and vomiting may develop after exposure).
 
The degumming process itself also has undesirable effects such as contaminating oil with inorganic phosphates, degrading recovered phospholipids, and corroding stainless steel equipment.
 
(ii) Neutralization:
The degummed oil undergoes neutralization with a caustic alkaline solution followed by acid treatment. There are concerns that neutralization impairs the nutritional quality of oils, particularly the vitamin, mineral and protein content, and also adds potential carcinogenic compounds such as nitrosamines.
 
(iii) Bleaching:
The neutralized oil is then bleached which has the unfortunate effects of removing nutrients such as carotenoids and causing the fatty acids to go rancid.
 
(iv) Deodorization:
After the bleaching process, the oil is deodorized which eliminates beneficial components such as tocopherols from the oil.
 
Soybean oil deodorizer distillate is a waste product of the above soybean oil refining process. The soy
phytosterols are then removed from the soybean oil deodorizer distillate by various solvents.
 
This study describes various solvents used in the phytosterol removal process.
(a) Ethanol:
Ethanol is another name for alcohol. E.g most wines contain less than about 13% ethanol. A denaturant is added to industrial ethanol, which is a substance which makes the ethanol both unpalatable and poisonous.
 
(b) n-propanol:
Can injure eye tissue, cause skin irritation and may aggravate asthma-like conditions. In laboratory studies n-propanol has been shown to lower male fertility, harm the fetus and cause an increase in cancer.

(c) Hexane:
Hexane exposure has been linked with skin irritation, dry skin, pain in skin, irritation, pain and redness in eyes, abdominal pain, nausea, vomiting, drowsiness, dizziness, dullness, weakness, headache, upper airway irritation, breathing difficulty, muscle cramps, tinnitus, muscle wasting and symptoms of peripheral neuropathy in cases of chronic exposure.

Hexane can also cause cancer, and other serious health illnesses including reproductive and birth defects. Hexane has been linked to explosions in food processing units. It is a potent neurotoxin causing dangerous health effects in workers of food processing units.

(d) Cyclohexane:
Causes skin irritation, drowsiness, dizziness and may be fatal if swallowed and enters the airways.

(e) Petroleum ether (benzine):
Petroleum ether is a flammable liquid obtained in distilling petroleum and is used in cleaning and dyeing and as a motor fuel.

(f) Acetone:
May cause irritation to the eyes throat and respiratory system, mood swings, and nausea. In laboratory studies acetone has been shown to cause anemia and an increase in malformed sperm.

(g) Butanone:
Butanone is an irritant, causing irritation to the eyes and nose. Butanone has induced birth defects, liver tumours and mammary gland tumours in laboratory studies.

(h) Cyclohexanone:
Exposure to cyclohexanone can result in irritation to the eyes, nose, throat and skin. It may cause dizziness and unconsciousness. Studies have shown that cyclohexanone may cause cataracts.

(i) Benzene:
Benzene increases the risk of cancer, bone marrow failure and anemia.

(j) Toluene:
Toluene may cause liver, kidney neurological damage. It has been linked with irritation to the nose, throat and respiratory tract. Exposure to toluene may cause hallucinations, dizziness, drowsiness, slurred speech, tremors, respiratory depression, arrhythmias and convulsions. Coma and death can occur following substantial exposures.

After the soy phytosterols have been extracted by the above processes they are added to processed foods such as margarines, mayonnaises, vegetable oils, salad dressings, soy milk, orange juice, snack bars, low-fat milk and low-fat and non-fat beverages.
 
Is it healthy to eat these products that are manufactured in such an industrial manner? 
Read more ►

Friday 26 October 2012

Statin treatment increases the risk of death by 301% after balloon angioplasty

0 comments
This study was published in the Journal of the American College of Cardiology 1997 Oct;30(4):863-9
 
Study title and authors:
Effect of pravastatin on angiographic restenosis after coronary balloon angioplasty. The PREDICT Trial Investigators. Prevention of Restenosis by Elisor after Transluminal Coronary Angioplasty.
Bertrand ME, McFadden EP, Fruchart JC, Van Belle E, Commeau P, Grollier G, Bassand JP, Machecourt J, Cassagnes J, Mossard JM, Vacheron A, Castaigne A, Danchin N, Lablanche JM.
Division of Cardiology B, Hôpital Cardiologique, Lille, France. bertrandme@AOL.com
 
This study can be accessed at: http://www.ncbi.nlm.nih.gov/pubmed/9316510

This study investigated the effects of pravastatin treatment after coronary balloon angioplasty. (Coronary angioplasty is accomplished using a balloon-tipped catheter inserted through an artery in the groin or arm to enlarge a narrowing in a coronary artery). In a multicenter, randomized, double-blind trial, 695 patients were randomized to receive pravastatin (40 mg/day) or placebo for 6 months after successful balloon angioplasty.

The study found that the patients on statin treatment had a 301% increased risk of death compared to the patients receiving placebo.
Read more ►

Thursday 25 October 2012

Children with predominant margarine consumption have an increased risk for eczema and allergic sensitization

0 comments
This study can be accessed at Pediatric Allergy and Immunology 2006 Mar;17(2):85-93

Study title and authors:
Margarine and butter consumption, eczema and allergic sensitization in children. The LISA birth cohort study.
Sausenthaler S, Kompauer I, Borte M, Herbarth O, Schaaf B, Berg A, Zutavern A, Heinrich J; LISA Study Group.
GSF - National Research Centre for Environment and Health, Institute of Epidemiology, Neuherberg, Germany.

This study can be accessed at: http://www.ncbi.nlm.nih.gov/pubmed/16618357

The aim of the study was to assess the relationship between dietary intake of margarine and butter with eczema and allergic sensitization in two-year-old children. (Allergic sensitization is the development of antibodies to a substance that results in an allergic reaction). Data was analysed of the butter and margarine intake of 2,582 two-year-old children and the subsequent allergic outcome.

The study found:
(a) Predominant margarine intake was associated with a 110% increased risk of doctor-diagnosed eczema.
(b) Predominant margarine intake was associated with a 110% increased risk of allergic sensitization against inhalant allergens.
(c) No associations were found for butter intake.

The study shows that children with predominant margarine consumption had an increased risk for eczema and allergic sensitization, while butter intake was no predictor for allergic diseases.
Read more ►

Wednesday 24 October 2012

Margarine makes you fat

0 comments
This study was published in PLoS One 2011;6(8):e23384
 
Study title and authors:
Food composition of the diet in relation to changes in waist circumference adjusted for body mass index.
Romaguera D, Ängquist L, Du H, Jakobsen MU, Forouhi NG, Halkjær J, Feskens EJ, van der A DL, Masala G, Steffen A, Palli D, Wareham NJ, Overvad K, Tjønneland A, Boeing H, Riboli E, Sørensen TI.
Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, United Kingdom. d.romaguera-bosch@imperial.ac.uk
 
This study can be accessed at: http://www.ncbi.nlm.nih.gov/pubmed/21858094

The objective of the study was to ascertain the association of various foods with changes in waist circumference. The study included 48,631 men and women from five countries who were followed for 5.5 years.

Regarding butter and margarine, the study found:
(a) For each 100 calorie increase in butter consumption there was a .01 centimetre per year decrease in waist circumference.
(b) For each 100 calorie increase in margarine consumption there was a .03 centimetre per year increase in waist circumference.

The data from the study reveals higher butter consumption is associated with thinner waistlines whereas higher margarine consumption is associated with fatter waistlines.
Read more ►

Monday 22 October 2012

Older men with lower cholesterol die earlier

0 comments
This study was published in the European Heart Journal 2001 Apr;22(7):573-9
 
Study title and authors:
Cardiovascular risk factors and 10-year all-cause mortality in elderly European male populations; the FINE study. Finland, Italy, Netherlands, Elderly.
Menotti A, Mulder I, Nissinen A, Feskens E, Giampaoli S, Tervahauta M, Kromhout D.
Division of Public Health Research, National Institute of Public Health and the Environment, Bilthoven, The Netherlands.
 
This study can be accessed at: http://www.ncbi.nlm.nih.gov/pubmed/11259144

The aim of the study was to examine risk factors in relation to death rates in elderly populations of different European countries. The study included 2,285 men, aged 65 to 84, from Finland, the Netherlands and Italy who were followed for ten years.

Regarding cholesterol levels, the study found:
(a) Men from Finland with the lowest cholesterol had a 19% increased risk of death compared to the men from Finland with the highest cholesterol.
(b) Men from Finland with the lowest levels of high density lipoprotein (HDL) cholesterol had a 14% increased risk of death compared to the men from Finland with the highest levels of high density lipoprotein (HDL) cholesterol.
(c) Men from the Netherlands with the lowest cholesterol had a 5% increased risk of death compared to the men from the Netherlands with the highest cholesterol.
(d) Men from the Netherlands with the lowest levels of high density lipoprotein (HDL) cholesterol had a 5% increased risk of death compared to the men from the Netherlands with the highest levels of high density lipoprotein (HDL) cholesterol.
(e) Men from Italy with the lowest cholesterol had a 5% increased risk of death compared to the men from Italy with the highest cholesterol.
(f) Men from Italy with the lowest levels of high density lipoprotein (HDL) cholesterol had a 12% increased risk of death compared to the men from Italy with the highest levels of high density lipoprotein (HDL) cholesterol.

The data from the study shows that lower levels of cholesterol and lower levels of HDL cholesterol are associated with an earlier death in older men.
Read more ►

Sunday 21 October 2012

Statin use is associated with a 57% increased risk of age-related cataract

0 comments
This study was published in Optometry and Vision Science 2012 Aug;89(8):1165-71
 
Study title and authors:
Age-related cataract is associated with type 2 diabetes and statin use.
Machan CM, Hrynchak PK, Irving EL.
School of Optometry, University of Waterloo, Waterloo, Ontario, Canada.
 
This study can be accessed at: http://www.ncbi.nlm.nih.gov/pubmed/22797512

This study investigated the associations between age-related cataract, type 2 diabetes, and statin use. The study included 6,397 patients aged 1-93 years.

The study found:
(a) Statin users had a 57% increased risk of age-related cataract compared to non-users.
(b) The 50% probability of cataract in statin users occurred at age 51.7 and 54.9 years in patients with type 2 diabetes and without diabetes, respectively. In non-statin users, it was significantly later at age 55.1 and 57.3 years for patients with type 2 diabetes and without diabetes, respectively.

The results of the study show that statin use is associated with an increased risk of age-related cataract.
Read more ►

Higher cholesterol levels are associated with a lower risk of irregular heart beat

0 comments
This study was published in Circulation 1997 Oct 7;96(7):2455-61

Study title and authors:
Incidence of and risk factors for atrial fibrillation in older adults.
Psaty BM, Manolio TA, Kuller LH, Kronmal RA, Cushman M, Fried LP, White R, Furberg CD, Rautaharju PM.
Department of Medicine, University of Washington, Seattle, USA.

This study can be accessed at: http://www.ncbi.nlm.nih.gov/pubmed/9337224

Atrial fibrillation is the most common type of irregular heart beat. It may cause no symptoms, but it is often associated with palpitations, fainting, chest pain, or congestive heart failure.

This study aimed to describe the incidence of atrial fibrillation among older adults. The study included 4,844 adults aged over 65 who were followed for an average of 3.28 years.

Regarding cholesterol levels, the study found for each increase of one mmol/L (38 mg/dL) of cholesterol the risk of atrial fibrillation was reduced by 14%.
Read more ►

Saturday 20 October 2012

Statins increase the risk of erectile dysfunction by 51%

0 comments
This study was published in the Journal of Clinical Pharmacy and Therapeutics 1996 Apr;21(2):89-94.

Study title and authors:
Men treated with hypolipidaemic drugs complain more frequently of erectile dysfunction.
Bruckert E, Giral P, Heshmati HM, Turpin G.
Service d'Endocrinologie-Métabolisme, Hôpital de la Pitié-Salpêtrière, Paris, France.

This study can be accessed at: http://www.ncbi.nlm.nih.gov/pubmed/8809645

The objective of this study was to assess whether there is an association between impotence and treatment with cholesterol lowering drugs. The study included 339 men taking cholesterol lowering drugs and 339 controls.

The study found:
(a) Men taking statins had a 51% increased risk of erectile dysfunction compared to men not taking cholesterol lowering drugs.
(b) Men taking fibrates had a 46% increased risk of erectile dysfunction compared to men not taking cholesterol lowering drugs.

The results from the study show that men taking cholesterol lowering drugs have an increased risk of erectile dysfunction.
Read more ►

Friday 19 October 2012

Cancer patients have low HDL cholesterol levels years before diagnosis - Best way to raise HDL is to eat saturated fat

0 comments
This study was published in the Journal of American College of Cardiology 2012;59(13s1):E1764-E1764.

HIGH-DENSITY LIPOPROTEIN CHOLESTEROL AND CANCER INCIDENCE: DATA FROM THE FRAMINGHAM HEART STUDY
Paul Michael Lavigne; Haseeb Jafri; Richard Karas

This study can be accessed at: http://content.onlinejacc.org/article.aspx?articleid=1205851
 
This study investigated the association of high-density lipoprotein (HDL) cholesterol levels with the incidence of cancer. The study included 201 cases of cancer and 402 matched controls. Their HDL cholesterol levels were measured at four time points throughout an average of 18.7 years prior to diagnosis of cancer.
 
The study found that HDL cholesterol levels were lower in cancer subjects than matched controls at each point of assessment throughout the 18.7 years prior to diagnosis.
 
The best way to raise your HDL cholesterol levels is to consume a diet rich in saturated fat, see here.


Read more ►

Tuesday 16 October 2012

Middle-aged men and women who consume the most saturated fat live longer and have a reduced risk of dying from cardiovascular diseases

0 comments
This study was published in the Journal of Internal Medicine 2005 Aug;258(2):153-65
 
Study title and authors:
Dietary fat intake and early mortality patterns--data from The Malmö Diet and Cancer Study.
Leosdottir M, Nilsson PM, Nilsson JA, Månsson H, Berglund G.
Department of Medicine, Lund University, University Hospital (UMAS), Malmö, Sweden. margret.leosdottir@med.lu.se
 
This study can be accessed at: http://www.ncbi.nlm.nih.gov/pubmed/16018792

This study examined the association of fat consumption with death rates. The study included 28,098 middle-aged individuals who were followed for an average of 6.6 years.

The study found:
(a) Women who consumed the most saturated fat had an 11% reduced risk of death compared to women who consumed the least saturated fat.
(b) Men who consumed the most saturated fat had a 9% reduced risk of death compared to men who consumed the least saturated fat.
(c) Women who consumed the most saturated fat had a 45% reduced risk of a cardiovascular disease death compared to women who consumed the least saturated fat.
(d) Men who consumed the most saturated fat had a 6% reduced risk of a cardiovascular disease death compared to men who consumed the least saturated fat.

The data from the study reveals that middle-aged men and women who consume the most saturated fat live longer and have a reduced risk of dying from cardiovascular diseases.
Read more ►

Monday 15 October 2012

Statin use is associated with a higher incidence of pneumonia

0 comments
This study was presented at the 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy Sep 09, 2012

Study title and authors:
The Impact of Statins on the Incidence of Bacteremia and Pneumonia in Military Personnel
K. R. Daniels, I. A. Mansi, J. P. Magulick, C. U. Oramasionwu, E. M. Mortensen, M. V. Pugh,  C. R. Frei
UT Austin & UT Hlth Sci Ctr, San Antonio, TX

This study can be accessed at: http://www.abstractsonline.com/Plan/ViewAbstract.aspx?sKey=43ceab1e-be2b-4b51-a293-09718162c582&cKey=ca5a9c68-c5c4-4a2f-8091-644c85397879&mKey=%7b6B114A1D-85A4-4054-A83B-04D8B9B8749F%7d

This study sought to determine if statin use is associated with bacteremia or pneumonia. The study included 14,821 statin-users and 52,787 non-users.

The study found:
(a) There was no difference in the incidence of bacteremia in statin users and non-users.
(b) Statin users had a 15% increased risk of pneumonia compared to non-users.

The study found that statin use is associated with a higher incidence of pneumonia.
Read more ►

Sunday 14 October 2012

Higher cholesterol levels are associated with better balance function in stroke patients

0 comments
This study was published in the Journal of Neurology Research Vol. 2, No. 4, Aug 2012
 
Study title and authors:
Higher Serum Total Cholesterol Levels are Associated With Better Long-Term Balance Function After First-Time Ischemic Stroke
Hung-Pin Lee, Yen-Ho Wang, Ching-Lin Hsieh, Yih-Tsen Lai, Shin-Liang Pan
 
This study can be accessed at: http://www.neurores.org/index.php/neurores/article/viewArticle/130

The objective of the study was to investigate the effects of cholesterol levels on long-term balance function in patients with first-time ischemic stroke. The study included 99 first-time ischemic stroke patients who were divided into two groups according to cholesterol levels:
(i) Higher cholesterol group(greater than or equal to 5.17 mmol/L or 200 mg/dL)
(ii) Lower cholesterol group (lower than 5.17 mmol/L or 200 mg/dL).

Balance function was measured using the Postural Assessment Scale for Stroke Patients (PASS). PASS contains 12 questions, each scored between 0 and 3 that measure the ability of stroke patients to maintain a given posture and the ability to ensure equilibrium in changing positions. A higer PASS score denotes better balance.

The study found the higher cholesterol group had 57% higher PASS scores than the lower cholesterol group.

The data from the study shows that higher cholesterol levels are associated with better balance function in first-time ischemic stroke patients.
Read more ►

Men who consume the most animal fat have a 10% reduced risk of heart disease

0 comments
This study was published in the British Journal of Nutrition 1993 Mar;69(2):303-14
 
Study title and authors:
Diet and incident ischaemic heart disease: the Caerphilly Study.
Fehily AM, Yarnell JW, Sweetnam PM, Elwood PC.
Medical Research Council Epidemiology Unit, Llandough Hospital, Penarth, South Glamorgan.
 
This study can be accessed at: http://www.ncbi.nlm.nih.gov/pubmed/8387811

The study investigated the association between diet and heart disease. The study lasted for five years and included 2,512 men aged 45-59 years when first seen.

Regarding animal fat consumption the study found that men who consumed the most animal fat had a 10% reduced risk of heart disease compared to the men who consumed the least animal fat.
Read more ►

Saturday 13 October 2012

Statins increase the risk of death in four year trial

0 comments
This study was published in Circulation 2004 Nov 2;110(18):2809-16

Study title and authors
Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria.
Asselbergs FW, Diercks GF, Hillege HL, van Boven AJ, Janssen WM, Voors AA, de Zeeuw D, de Jong PE, van Veldhuisen DJ, van Gilst WH; Prevention of Renal and Vascular Endstage Disease Intervention Trial (PREVEND IT) Investigators.
Department of Clinical Pharmacology, University of Groningen, Groningen, The Netherlands.

This study can be accessed at: http://www.ncbi.nlm.nih.gov/pubmed/15492322

One of the aims of this study was to investigate the effect of statins on people aged 28 to 75 years old. This section of the study, which lasted nearly four years, included 217 people who were given statins and 216 people who were given a placebo.

The study found that those given statins had a 6% increased risk of death compared to those given a placebo.

Read more ►

Friday 12 October 2012

Men who consume the most cholesterol, meat and saturated fat live the longest

0 comments
This study was published in the American Journal of Clinical Nutrition 1989 Nov;50(5):1095-103
 
Study title and authors:
Diet and 20-y mortality in two rural population groups of middle-aged men in Italy.
Farchi G, Mariotti S, Menotti A, Seccareccia F, Torsello S, Fidanza F.
Laboratorio di Epidemiologia e Biostatistica, Istituto Superiore di Sanità, Roma, Italy.
 
This study can be accessed at: http://www.ncbi.nlm.nih.gov/pubmed/2816794

This study analysed the relationship of diet on cardiovascular disease and death rates. The study included 1,536 men aged 45-64 who were followed for 20 years.

After 15 years the study found:
(a) Men who were alive consumed 8.7% more fat than men who had died.
(b) Men who were alive consumed 18.1% more fat than men who had died of heart disease.
(c) Men who were alive consumed 7.4% more saturated fat than men who had died.
(d) Men who were alive consumed 21.4% more saturated fat than men who had died of heart disease.

The men were also analysed by a different method whereby they were divided up into four different groups where each group represented a different dietary pattern. For example group (1) consumed the least cholesterol, meat and saturated fat whereas group (3) consumed the most cholesterol, meat and saturated fat. The consumption amounts of groups (2) and (4) were intermediate between groups (1) and (3).

After analylising the data, the researchers found that after 20 years those men in group (1) (the lowest consumers of cholesterol, meat and saturated fat) had a 25.1% increased risk of death compared to the men in group (3) (the highest consumers of cholesterol, meat and saturated fat). The death rates of groups (2) and (4) were intermediate between groups (1) and (3).

The data from the study shows that men who consume the most cholesterol, meat and saturated fat live the longest.
Read more ►

Wednesday 10 October 2012

Statins increase the risk of death by 4.3%

0 comments
This study was published in the Journal of the American Medical Association 1998 May 27;279(20):1615-22

Study title and authors:
Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.
Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA, Langendorfer A, Stein EA, Kruyer W, Gotto AM Jr.
Wilford Hall Medical Center, Lackland Air Force Base, San Antonio, Tex, USA.

This study can be accessed at: http://www.ncbi.nlm.nih.gov/pubmed/9613910

This study investigated the effect of statin treatment on men and women without cardiovascular disease, with average total cholesterol and average low-density lipoprotein cholesterol (LDL) levels and below-average high-density lipoprotein cholesterol (HDL) levels. The study included 5,608 men and 997 women who were given either lovastatin (20-40 mg daily) or placebo and followed for an average of 5.2 years.

The study found that those given the statins had a 4.3% increased risk of death compared to those given the placebo.
 
Read more ►

Tuesday 9 October 2012

Men who consume the most fat and saturated fat live longer and have a lower risk of dying from heart disease

0 comments
This study was published in the American Journal of Clinical Nutrition 1980 Aug;33(8):1818-27
 
Study title and authors:
Relationship of dietary intake to subsequent coronary heart disease incidence: The Puerto Rico Heart Health Program.
Garcia-Palmieri MR, Sorlie P, Tillotson J, Costas R Jr, Cordero E, Rodriguez M.
 
This study can be accessed at: http://www.ncbi.nlm.nih.gov/pubmed/7405884

This study investigated the relationship between intakes of various nutrients and total death rates and heart disease death rates. The study included 8,218 urban and rural Puerto Rican man aged 45 to 64 who were followed for six years.

Regarding fat and saturated fat intake, the study found:
(a) Urban men who died consumed 12% less fat compared to the urban men who survived.
(b) Urban men who died consumed 11% less saturated fat compared to the urban men who survived.
(c) Urban men who died of heart disease consumed 2% less fat compared to the urban men who survived.
(d) Urban men who died of heart disease consumed 5% less saturated fat compared to the urban men who survived.
(e) Rural men who died consumed 12% less fat compared to the rural men who survived.
(f) Rural men who died consumed 12% less saturated fat compared to the rural men who survived.
(g) Rural men who died of heart disease consumed 13% less fat compared to the rural men who survived.
(h) Rural men who died of heart disease consumed 9% less saturated fat compared to the rural men who survived.
(i) Urban men who died consumed 10% less cholesterol compared to the urban men who survived.
(j) Rural men who died consumed 8% less cholesterol compared to the rural men who survived.

The data from the study reveals that men who consume the most fat and saturated fat live longer and have a lower risk of dying from heart disease. 
Read more ►

Monday 8 October 2012

Benzodiazepines increase the risk of dementia by 60%

0 comments
This study was published in the British Medical Journal 345 e:6231 27 Sep 2012

Study title and authors:
Benzodiazepine use and risk of dementia: prospective population based study

Sophie Billioti de Gage, Bernard Bégaud, Fabienne Bazin, Hélène Verdoux, Jean-François Dartigues, Karine Pérès, Tobias Kurth, Antoine Pariente. 

This study can be accessed at: http://www.bmj.com/content/345/bmj.e6231.pdf%2Bhtml

The objective of the study was to evaluate the association between the use of benzodiazepines and dementia. The study included 1,063 men and women, average age 78 years, who were followed for 15 years.
 
Benzodiazepines are a group of medications which have been used since the 1960s to treat anxiety, epileptic seizures, mania, alcohol withdrawal and sleeping problems.
 
The list below shows some of the different generic and brand names of benzodiazepines.
  • diazepam - Valium, Ducene, Antenex
  • oxazepam - Serepax, Murelax, Alepam
  • nitrazepam - Mogadon, Alodorm
  • temazepam - Euhypnos, Normison, Temaze
  • lorazepam - Ativan
  • flunitrazepam - Rohypnol, Hypnodorm
  • bromazepam - Lexotan
  • clonazepam - Rivotril

The study found that users of benzodiazepines had a 60% increased risk of dementia compared to non-users.
Read more ►

Sunday 7 October 2012

Low cholesterol levels lead to an increased risk of intracerebral hemorrhagic stroke

0 comments
This study was published in the Annalls of Indian Academy of Neurology 2012 Jan;15(1):19-22
 
Study title and authors:
Low cholesterol as a risk factor for primary intracerebral hemorrhage: A case-control study.
Valappil AV, Chaudhary NV, Praveenkumar R, Gopalakrishnan B, Girija AS.
Department of Neurology, Malabar Institute of Medical Sciences, Calicut, Kerala, India.
 
This study can be accessed at: http://www.ncbi.nlm.nih.gov/pubmed/22412267

This study investigated the association between cholesterol levels and the risk of intracerebral hemorrhagic stroke. The study included 74 patints with intracerebral hemorrhage and 74 control subjects.

The study found:
(a) The intracerebral hemorrhage patients cholesterol levels were 11.5% lower than the control subjects.
(b) The intracerebral hemorrhage patients low density lipoprotein (LDL) cholesterol levels were 11.0% lower than the control subjects.
(c) The intracerebral hemorrhage patients high density lipoprotein (HDL) cholesterol levels were 9.0% lower than the control subjects.
(d) Those with the lowest cholesterol levels had a 115% increased risk of intracerebral hemorrhage.

The study shows the association between low cholesterol levels and an increased risk of intracerebral hemorrhagic stroke.
Read more ►

Low cholesterol levels are associated with increased stroke severity and increased short- and long-term death rates

0 comments
This study was published in Cerebrovascular Diseases 2012 Sep 18;34(3):213-220

Study title and authors:
Low Cholesterol, Statins and Outcomes in Patients with First-Ever Acute Ischemic Stroke.
Koton S, Molshatzki N, Bornstein NM, Tanne D.
The Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

This study can be accessed at: http://www.ncbi.nlm.nih.gov/pubmed/23006641

The study assessed the association between cholesterol levels and first-ever ischemic stroke short- and long-term outcomes. The study included 1,895 ischemic stroke patients, average age 67.4 years.

The study found:
(a) Low cholesterol levels were significantly associated with severe strokes.
(b) Patients with low cholesterol levels (less than 155 mg/dL or 4.0 mmol/L) had a 108% increased risk of death at discharge compared to patients with higher cholesterol levels.
(c) Patients with low cholesterol levels (less than 155 mg/dL or 4.0 mmol/L) had a 71% increased risk of death after three years compared to patients with higher cholesterol levels.

The results of the study show that low cholesterol levels are associated with increased stroke severity and increased short- and long-term death rates.
Read more ►

Friday 5 October 2012

Low cholesterol levels are associated with lower survival rates in stroke patients

0 comments
This study was published in the European Journal of Neurology 2012 Apr;19(4):648-54
 
Study title and authors
Serum cholesterol levels and survival after rtPA treatment in acute stroke.
Roquer J, Cuadrado-Godia E, Rodríguez-Campello A, Jiménez-Conde J, Martínez-Rodríguez JE, Giralt E, Ois A.
Servei de Neurologia, Hospital del Mar, Parc de Salut Mar-IMIM, Barcelona, Spain. jroquer@hospitaldelmar.cat
 
This study can be accessed at: http://www.ncbi.nlm.nih.gov/pubmed/22136724

The aim of this study was to analyze the impact of cholesterol levels on 3-month death rates in patients with ischaemic stroke treated with intravenous recombinant tissue plasminogen activator (rtPA) and admitted to a monitored acute stroke unit. The study included 220 patients, average age of 73 years.

(a) Those with the lowest cholesterol, (less than 155 mg/dL or 4.0 mmol/L) had death rates of 25.7%.
(b) Those with cholesterol levels in the middle range, (155-192 mg/dL or 4.0-5.0 mmol/L) had death rates of 13.7%.
(c) Those with the highest cholesterol, (over 192 mg/dL or 5.0 mmol/L) had death rates of 5.5%.

The results of the study show that low cholesterol levels are associated with lower survival rates in stroke patients.
Read more ►

Thursday 4 October 2012

Low cholesterol levels associated with poor outcome in patients hospitalized with heart failure

0 comments
This study was published in the Journal of Cardiac Failure 2012 Mar;18(3):194-201
 
Study title and authors:
Low serum total cholesterol level is a surrogate marker, but not a risk factor, for poor outcome in patients hospitalized with acute heart failure: a report from the Korean Heart Failure Registry.
Yoon CH, Youn TJ, Ahn S, Choi DJ, Cho GY, Chae IH, Choi J, Cho H, Han S, Cho MC, Jeon ES, Chae SC, Kim JJ, Ryu KH, Oh BH; Korean Heart Failure Registry.
Cardiovascular Center, Seoul National University Bundang Hospital, Seoul, South Korea.
 
This study can be accessed at: http://www.ncbi.nlm.nih.gov/pubmed/22385939

This study evaluated the effect of cholesterol levels on patients hospitalized due to heart failure. The study included 2,797 heart failure patients.

The study found that the patients with the lowest cholesterol levels, had a 57% increased risk of death and readmission to hospital due to heart failure compared to the patients with the highest cholesterol levels.


Read more ►

I've published another book!

0 comments
I've made a another foray into publishing with a book titled "Low Cholesterol Leads To An Early Death: Evidence From 101 Scientific Papers".

Contrary to public perception, statistics from the scientific literature actually show that having LOW cholesterol means you are more likely to die earlier.

The book, in which Tom Naughton (of Fat-Head fame) very kindly penned the foreword, cites the evidence of 101 scientific papers and shows: 

·         Low cholesterol levels are associated with a shorter life.
·         Low levels of HDL and LDL cholesterol are linked to a shorter life-span.
·         High cholesterol does NOT cause heart disease.
·         Low cholesterol leads to illness and death in many diseases and conditions.
·         Statin drugs and low-fat diets may lead to higher death rates.
·         Saturated fat can give protection from heart disease.
·         Cholesterol is an essential substance needed for a long healthy life.

This book is based on the research of doctors, professors and scientists and includes 101 scientific papers, the findings of which are explained in an easy to read user friendly format.

This information will enable readers to make informed choices about the alleged wisdom of actively trying to lower their cholesterol levels.

So the next time you are given the message to "lower your cholesterol" by health care practitioners, friends or family, show them this book with its 101 peer-reviewed scientific studies that show low cholesterol levels lead to an early death.

The book is available on Amazon or at any good bookshop.

Buy from Amazon US here
Buy from Amazon UK here
Buy from Amazon DE here
Buy from Amazon FR here

Buy from kindle US here
Buy from kindle UK here
Buy from kindle DE here
Buy from kindle FR here
Read more ►

Tuesday 2 October 2012

High cholesterol significantly reduces the risk of breast cancer

0 comments
This study was published in Ethnicty and Disease 2012 Summer;22(3):281-7

Study title and authors:
Cholesterol, lipoproteins, and breast cancer risk in African American women.
Llanos AA, Makambi KH, Tucker CA, Wallington SF, Shields PG, Adams-Campbell LL.
Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20057, USA.

This study can be accessed at: http://www.ncbi.nlm.nih.gov/pubmed/22870570

The study investigated the relationship between cholesterol levels and the risk of breast cancer. The study included 97 African American women with breast cancer and 102 control subjects.

The study found:
(a) Higher levels of cholesterol were associated with a 54% reduction in breast cancer risk.
(b) Higher levels of Low Density Lipoprotein (LDL) cholesterol were associated with a 59% reduction in breast cancer risk.
(c) Lower levels of High Density Lipoprotein (HDL) cholesterol were associated with a 99% increase in breast cancer risk.

The data from the study demonstrates significant reductions in breast cancer risk with high levels of total cholesterol & LDL cholesterol and significant increase in risk when HDL cholesterol levels are low.
Read more ►

Monday 1 October 2012

Patients hospitalised with mental illness have lower cholesterol levels than the general public

0 comments
This paper was published in Psychiatric Services 2012 Mar;63(3):294-5
 
Study title and authors:
Unexpectedly low cholesterol levels among New York State inpatients.
Essock SM, Jackson CT, Kent L.

This paper can be accessed at: http://www.ncbi.nlm.nih.gov/pubmed/22388541

This paper compared cholesterol levels in:
(i) 3,792 New York State Office of Mental Health Hospital patients, (from 17 hospitals) aged 18 and over, with severe and persistent mental illness.
(ii) The general US public.

The paper found:
(a) The mental hospital patients with cholesterol levels over 200 mg/dL (5.1 mmol/L) ranged from 11% to 36% across the 17 hospitals.
(b) US national data indicates that from 40% to 51% of the US public have cholesterol levels over 200 mg/dL (5.1 mmol/L), depending on their ethnic background.

This paper shows that patients hospitalised with mental illness have lower cholesterol levels than the general public.
Read more ►
 

Copyright © Healthy Diets New Design by O Pregador | Blogger Theme by Blogger Template de luxo | Powered by Blogger